We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -0.63% | 39.25 | 39.00 | 39.50 | 39.50 | 39.25 | 39.50 | 11,246 | 08:47:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 95.73 | 49.39M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/2/2018 11:20 | That's because I hold SDX Apad. If I didn't it would be positive even in this market! Ho hum.... At least HOC wasn't as smashed as I thought it would be although they had a good go at the start of the session. Still plenty of time for it to be smashed again and the US isn't open yet! | lauders | |
06/2/2018 11:17 | SDX going nowhere on decent news. GSK final tomorrow, red. An initial markdown at first, when the tintins dust off their usual story, perhaps. apad | apad | |
06/2/2018 11:08 | Topped up my DOTD at 82.5p, FWIW. Also, bought back some FEVR first thing having top-sliced a couple of weeks ago. I'm drip feeding cash in to the market where I see good opportunities rather than buying big. | madmix | |
06/2/2018 11:04 | I've got several up now GAW will prob end blue too | big7ime | |
06/2/2018 10:39 | It is definitely roulette wheel time. I have just dipped a toe into stocks that I am happy to hold for the duration, at prices that are 'reasonable' given some degree of sense in the markets. Bought back a few PTSG having taken profit on my original stake. I am risking that profit of £322 now. I hope to get a 'dividend' sometime in 2018 on Bree by selling trading stock. Gsk is yielding c6% and I have topped up those held in my ISA. At some point I hope to sell out, at a good profit, after taking a few dividends along the way. Onwards and downwards? Like my ill timed purchases of RWS and Hils:-( red | redartbmud | |
06/2/2018 10:35 | Big I wouldn't sell most of my portfolio regardless of the market if there is no company specific reason to sell. I have a good cash balance after last years 3 digit performance so ammunition for the odd purchase where I feel there is a bargain. Obviously people have different thresholds but agree that most important thing is to be comfortable with your overall level of risk/cash | hydrus | |
06/2/2018 10:24 | 16923 yes this is nothing in a bear market, stocks that you think are dirt cheap, can half in value selling begets more selling and value is disregarded just saying because i've seen it before | spob | |
06/2/2018 10:19 | Sometimes what you'd think the most likely doesn't happen, and opposite occurs IQE up 3% I think those naughty shorters are closing | big7ime | |
06/2/2018 10:16 | Wait till you've lived through many crashes, this isn't a crash at the moment, just a correction but it could turn into one. It needs a trigger and I don't think interest rates are it. Apad if you're nervous of being down a few percent prepare for 20-30 I'm keeping my powder dry until some more obvious bargains It doesn't matter how good the co is, that's a mistake When they fall enmasse those that have risen a lot will fall heavily as you have seen Apad. Common sense goes out the window, people don't like to see their profit disappear The quality recover quickly though | big7ime | |
06/2/2018 10:04 | I've dipped my toe in. A few companies looking tempting. Will not put whole foot in though just yet...... | hydrus | |
06/2/2018 10:02 | A few making rare acquaintance with the 200 day - e.g.DOTD/AMS/FFX - can't see any pattern. The likes of ABC and the untraded ARC are immune. Probably not a sensible measure in these frenetic markets. Not sure what there is to learn from this market reaction. Any votes on a yoodle bounce this affy? Don't like being 1.7% down on the year :-) apad | apad | |
06/2/2018 09:22 | HL. reported 1H results to 31 Dec. A couple items re: JIM, a comparetition holding for me. HL reported that: "volumes in the current financial year have remained high and are 8% ahead of H1 17 in absolute terms" This should be positive for JIM as 2H forecast was flat to declining relative to 2H16. HL earned 43bps of net interest margin (relative to 35-45bps original guidance). Now guiding to 40-50bps for full year to 30 Jun. They say majority of the cash is placed on rolling 13 month term deposits via SIPPs. JIM earn several multiples of HL net interest margin but hopefully supportive of interest rates having bottomed. If true, suggests that net interest margin should grow at rate of growth of cash under administration or more than that in the event of an interest rate hike. | gsbmba99 | |
06/2/2018 09:14 | ptsg was on my shopping list but you got a better p[rice than I. Had hoped abc would be marked down; been waiting for a dip but it doesn't happen. added a few ztf as well. | janeann | |
06/2/2018 09:01 | Well done. Did tuck away 300 Gsk @1253.4p in ISA 6%+ yield for the long term. red | redartbmud | |
06/2/2018 08:58 | ams - order finally dealt at 283.5. youinvest - can be good. better than they were. and at 4.95 trade cost at 10 trades /per month that's ok! (nearly makes buying 50 arc shares justifiable!) | janeann | |
06/2/2018 08:55 | Bought 5k Bree @76.45p red | redartbmud | |
06/2/2018 08:47 | AMS well below the 200day, j. Doesn't often go there. Who's your trade with? apad | apad | |
06/2/2018 08:34 | have had a limit order in on ams above the offer price and still isn't filled. Yet I can sell those I have quite easily! Bizarre. | janeann | |
06/2/2018 06:48 | Excerpt from FT "IQE is already one of the most shorted stocks in the UK. Its share price has fallen about 40 per cent since November. Yet it responded dismissively to the claims of a little-known outfit with a name worthy of a James Bond movie title: ShadowFall. This is run by a bear raider known as “The Dark Destroyer”, previously the nom de guerre of boxer Nigel Benn. Appropriately, ShadowFall pulls no punches in a 35-page dossier on IQE. Here, it revives memories of Globo, the Greek technology group founded by a windsurfing champion that went into administration in 2015 amid allegations of falsified data. ShadowFall said IQE appeared to rely on two joint ventures — one in Cardiff, another in Singapore — for a chunk of earnings. It argued IQE’s relationship with these joint ventures was “somewhat circular” as their only customer appeared to be IQE itself. Significantly, it argued, IQE had run up significant profits while the joint venture retained growing losses. IQE has a history of covering cash shortfalls by raising fresh capital. But the criticisms still look overdone. The details of the joint ventures — set up to further links between IQE, academia and others — are disclosed in audited documents. The joint ventures now have external customers, albeit unnamed. IQE’s license income from joint ventures is expected to be less than £2m in 2017. The company said the ShadowFall report amounted to a “fundamental misrepresentation Nor does IQE resemble Autonomy or Quindell, UK technology companies that had accounting controversies of their own. Unlike software, where revenue recognition has been a thorny problem, the accounting treatment of chip sales is straightforward. A bigger question is whether IQE deserves the hype that pushed its share price up fourfold between January and November. Much of the excitement was generated by speculation IQE was selling chips needed by Apple for its new iPhone. The company says non-disclosure agreements mean it cannot confirm the story. Investors are weighing the accuracy of a report from a mysterious short seller that nobody has heard of. What matters more is the accuracy of reports identifying a mysterious customer as one of the world’s most famous companies." | apad | |
06/2/2018 06:37 | And now lol | panic investor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions